Blog - INTERNET MÉDICA

Hemofilia: Diretrizes Médicas (Hemophilia: Guideline)

Por Paulo Leite 28/02/2021

■ International recommendations on the diagnosis and treatment of acquired hemophilia A

Andreas Tiede, Peter Collins, Paul Knoebl, et al

Haematologica. 2020 Jul; 105(7): 1791–1801

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327664/

■ WFH Guidelines for the management of hemophilia, 3^rd edition

A Srivastava, E Santagostino, A Dougall et al

Haemophilia 2020, vol 26, issue S6

https://onlinelibrary.wiley.com/doi/10.1111/hae.14046

■ Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumabb: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET

Giancarlo Castaman, Cristina Santoro, Antonio Coppola et al

Blood Transfus. 2020 Mar; 18(2): 143–151.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141940/

■ Position paper on laboratory testing for patients with haemophilia. A consensus document from SISET, AICE, SIBioC and SIPMeL

Armando Tripodi, Rita C. Santoro, Sophie Testa, et al

Blood Transfus. 2019 May; 17(3): 229–236.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596380/

■ Kreuth V initiative: European consensus proposals for treatment of hemophilia using standard products, extended half-life coagulation factor concentrates and non-replacement therapies

Flora Peyvandi, Karin Berger, Rainer Seitz, et al

Haematologica. 2020 Aug; 105(8): 2038–2043

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395279/

■ Hemophilia A and B: molecular and clinical similarities and differences

Giancarlo Castaman, Davide Matino

Haematologica. 2019 Sep; 104(9): 1702–1709

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717582/

■ The UK haemophilia specialist nurse: competencies fit for practice in the 21^st century

Debra Pollard, Catherine Harrison, Sandra Dodgson et al

Haemophilia. 2020 Jul; 26(4): 622–630.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496226/

■ Evaluating international Haemophilia Joint Health Score (HJHS) results combined with expert opinion: options for a shorter HJHS

Isolde A.R. Kuijlaars, Janjaap van der Net, Brian M. Feldman et al

Haemophilia. 2020 Nov; 26(6): 1072–1080

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821332/

■ Pharmacokinetics in routine haemophilia clinical practice: rationale and modalities – a practical review

Cedric Hermans, Gerry Dolan

Ther Adv Hematol. 2020; 11: 2040620720966888

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594230/

■ Efficacy and safety of simoctocog alfa in patients with severe hemophilia A: a review of clinical trial data from the GENA program

Toshko Lissitchkov, Anna Klukowska, John Pasi, et al

Ther Adv Hematol. 2019; 10: 2040620719858471

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595650/

■ The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition

Donat R. Spahn, Bertil Bouillon, Vladimir Cerny et al

Crit Care. 2019; 23:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436241/

■ Hemofilia (Hemophilia)

Arquivo Blog Internet Médica – setembro 2019

https://internetmedica.com.br/hemofilia-online-hemophilia/

■ Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Blog Internet Médica – www.internetmedica.com.br

Data: fevereiro 2021

Leucemia: Diretrizes Médicas (Leukemia: Guidelines)

Por Paulo Leite 27/02/2021

■ American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults

Mikkael A. Sekeres, Gordon Guyatt, Gregory Abel et al

Blood Adv. 2020 Aug 11; 4(15): 3528–3549

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422124/

■ Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia

Jorge E. Cortes, Marcos de Lima, Hervé Dombret, et al

J Hematol Oncol. 2020; 13: 137.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559451/

■ Recent drug approvals for acute myeloid leukemia

Catherine Lai, Kimberley Doucette, Kelly Norsworthy

J Hematol Oncol. 2019; 12: 100.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749668/

■ Validation and refinement of the revised ,2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia

Tobias Herold, Maja Rothenberg-Thurley, Victoria V. Grunwald et al

Leukemia. 2020; 34(12): 3161–3172

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685975/

■ Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Ali Bazarbachi, Gesine Bug, Frederic Baron et al

Haematologica. 2020 Jun; 105(6): 1507–1516

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271578/

■ CAR T cells for acute myeloid leukemia: state of the art and future directions

Sherly Mardiana, Saar Gill

Front Oncol. 2020; 10: 697

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218049/

■ Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL – ERIC recommendations.

Zalcberg, Ilana et al.

Hematol., Transfus. Cell Ther., Sept 2020, vol.42, no.3, p.269-274

https://www.scielo.br/scielo.php?script=sci_arttext&pid=S2531-13792020000300269&lng=pt&nrm=iso

■ European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

Hochhaus, M. Baccarani, R. T. Silver et al

Leukemia. 2020; 34(4): 966–984

https://www.nature.com/articles/s41375-020-0776-2

■ Genetics and epigenetics of leukemia and lymphoma: from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research Institute

Maribel Parra, Maria Joao Baptista, Eulàlia Genescà et al

Hematol Oncol. 2020 Oct; 38(4): 432–438

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687178/

■ Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions

Bachar Samra, Elias Jabbour, Farhad Ravandi, Hagop Kantarjian, Nicholas J. Short

J Hematol Oncol. 2020; 13: 70

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275444/

■ Expert opinion – management of chronic myeloid leukemia after resistance to second-generation tyrosine kinase inhibitors

Andreas Hochhaus, Massimo Breccia, Giuseppe Saglio et al

Leukemia. 2020; 34(6): 1495–1502

https://www.nature.com/articles/s41375-020-0842-9

■ European recommendations ad quality assurance for cytogenomic analysis of haematological neoplasms: response to the comments from the Francophone Group of Hematological Cytogenetics (GFCH)